Technology News and Research

RSS

BioMimetic highlights updates on orthopedic and rehabilitation devices during AAOS meeting

BioMimetic Therapeutics, today announced highlights from its analyst and investor meeting which was held on Thursday, February 17 in San Diego, CA in conjunction with the American Academy of Orthopedic Surgery Annual Meeting.

18 Feb 2011

Pittsburgh researchers awarded funds for testing brain-computer interfaces in patients with spinal cord injuries

Researchers at the University of Pittsburgh have been awarded funding for two projects that will place brain-computer interfaces (BCI) in patients with spinal cord injuries to test if it is possible for them to control external devices, such as a computer cursor or a prosthetic limb, with their thoughts.

18 Feb 2011

First implantation of Amedica/US Spine's Infinia silicon nitride ceramic femoral head performed in hip replacement

Amedica/US Spine, a spine and reconstructive implant and instrument manufacturer focused on unique silicon nitride (SiN) technologies, implanted its first silicon nitride total hip implant this week in the international marketplace. A patient at the George Provincial Hospital in Western Cape South Africa received the implant that uses an Infinia silicon nitride ceramic femoral head as part of the total implant.

18 Feb 2011

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.

18 Feb 2011

Scottsdale Healthcare implants MRI-safe pacemaker

Scottsdale Healthcare Shea Medical Center is the first hospital in the southwestern United States to implant an MRI-safe pacemaker, a major technological breakthrough for patients who need MRI diagnostic scans, which can damage older style pacemakers or cause serious health complications.

18 Feb 2011

RyMed's InVision-Plus IV Connector decreases catheter-related bloodstream infections by 92.6%

Georgia Health Sciences University, Augusta, GA exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies' zero displacement InVision-Plus® IV Connector significantly decreased the incidence of catheter-related bloodstream infections (CR-BSIs) by 92.6% on average when compared to a simple split septum with negative displacement IV connector (Becton-Dickinson Q-Syte®) and a reversed split-septum device with negative displacement IV connector (ICU Medical Clave®).

18 Feb 2011

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell Technologies,™ Inc. today announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries) clinical trial. Stefan Verheye, M.D., Ph.D. at Middelheim Hospital, Antwerp, Belgium enrolled the first patient in the study. This clinical investigation is being conducted to support CE Mark approval of the company's MiStent™ Drug-Eluting Coronary Stent System (MiStent DES).

18 Feb 2011

China-Biotics applies 5 new patents for probiotics supplement, preparation

China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced it has applied for 5 new patents through its wholly owned subsidiary Growing Bioengineering to the State Bureau of Intellectual Property.

18 Feb 2011

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.

18 Feb 2011

Intrinsic initiates enrollment in Barricaid device clinical trial

Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid device.

18 Feb 2011

Massachusetts receives $35.6 million HHS grant to develop online health care exchanges

The University of Massachusetts Medical School, the Massachusetts Executive Office of Health and Human Services and the Massachusetts Connector Authority have received a $35.6 million grant from the U.S. Department of Health and Human Services to develop an online "health care exchange," a resource through which consumers and small business owners can efficiently shop for health insurance plans.

17 Feb 2011

Study: Preterm mothers’ milk contains low concentrations of coenzyme Q10

A study conducted at the University of Granada and at the University Hospital San Cecilio revealed that preterm mothers' milk contains low concentrations of coenzyme Q10. This is a complex of great medical importance, due both to its antioxidant capacity and to its role as a component of the electron transport chain, among other functions.

17 Feb 2011

FDA approves GORE VIABAHN device to treat peripheral artery disease

W. L. Gore & Associates today announced it has received FDA approval for the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system.

17 Feb 2011

Benitec strengthens patent position in RNAi

Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO’s confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.

17 Feb 2011

Ascom, Meru provide 802.11n wireless phone to healthcare industry

Meru Networks, the leader in virtualized 802.11n enterprise wireless networking, today announced that Ascom endorses Meru's AP300 Series with "deployment-proven" support for the Ascom i62, the latest generation of voice over Wi-Fi handsets.

17 Feb 2011

Stout Medical, Integra enter license agreement to develop, commercialize expandable interbody device

Integra LifeSciences Holdings Corporation announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.

17 Feb 2011

Ascom receives ISO certification for its medical devices

Ascom (US) Inc., is proud to announce that it has achieved ISO 9001 and ISO 13485 certification. ISO 13485 emphasizes meeting regulatory as well as customer requirements, risk management and maintaining effective processes, namely the processes specific to the safe design, manufacture and distribution of medical devices.

17 Feb 2011

Researchers find blue-green algae may be responsible for producing estrogen-like compound in water

University of Tennessee, Knoxville, researchers have found that blue-green algae may be responsible for producing an estrogen-like compound in the environment which could disrupt the normal activity of reproductive hormones and adversely affect fish, plants and human health.

17 Feb 2011

Unrecognized substances released by algae blooms may act as endocrine disruptors

Scientists are reporting for the first time that previously unrecognized substances released by algae blooms have the potential to act as endocrine disruptors, which can interfere with the normal activity of reproductive hormones. The effect is not caused by microcystin toxins, long recognized as potentially harmful to humans and aquatic animals, but as yet unidentified substances.

17 Feb 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health, Inc. today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient.

17 Feb 2011

Technology News and Research

BioMimetic highlights updates on orthopedic and rehabilitation devices during AAOS meeting

Pittsburgh researchers awarded funds for testing brain-computer interfaces in patients with spinal cord injuries

First implantation of Amedica/US Spine's Infinia silicon nitride ceramic femoral head performed in hip replacement

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

Scottsdale Healthcare implants MRI-safe pacemaker

RyMed's InVision-Plus IV Connector decreases catheter-related bloodstream infections by 92.6%

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

China-Biotics applies 5 new patents for probiotics supplement, preparation

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

Intrinsic initiates enrollment in Barricaid device clinical trial

Massachusetts receives $35.6 million HHS grant to develop online health care exchanges

Study: Preterm mothers’ milk contains low concentrations of coenzyme Q10

FDA approves GORE VIABAHN device to treat peripheral artery disease

Benitec strengthens patent position in RNAi

Ascom, Meru provide 802.11n wireless phone to healthcare industry

Stout Medical, Integra enter license agreement to develop, commercialize expandable interbody device

Ascom receives ISO certification for its medical devices

Researchers find blue-green algae may be responsible for producing estrogen-like compound in water

Unrecognized substances released by algae blooms may act as endocrine disruptors

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News